Single-Use Bioreactors Market to Reach USD 9.1 Billion by 2029

Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029
Market growth is driven by the increasing adoption of single-use technologies [https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html] among SMEs, CDMOs, and CMOs, along with the advantages of SUBs over traditional stainless-steel systems. These include lower capital costs, reduced water and energy usage, and greater flexibility.

However, issues such as leachables and extractables, regulatory challenges, and PFAS restrictions may limit growth. Despite these challenges, the development of hybrid facilities-which combine traditional and single-use systems-presents strong opportunities for cost efficiency and flexibility.

Download PDF Brochure: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750&utm_source=abnewswire&utm_medium=referral&utm_campaign=paidpr]

A key concern for manufacturers remains the risk of bag breakage, which can cause contamination and financial losses.

In 2023, single-use bioreactor systems and stirred-tank bioreactors dominated the market. North America led globally, supported by a strong biopharmaceutical R&D presence.

Major players include Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., and Merck KGaA.

Key Players

Sartorius AG - Leading Provider of Single-Use Bioreactor Solutions Sartorius AG serves biopharmaceutical and pharmaceutical companies, CMOs, and CROs with a wide portfolio of high-quality, technology-driven SUB solutions. Strong R&D investments and global expansion have strengthened its market position, driving continued growth in the single-use bioreactors sector.

Danaher Corporation - Innovator in Bioprocessing Technologies Through its subsidiary Cytiva, Danaher offers advanced solutions for cell culture, filtration, separation, and purification. Its single-use bioreactor technologies play a key role in drug, plasma, and vaccine production, making it a major force in the market.

Thermo Fisher Scientific Inc. - Comprehensive Single-Use Solutions Provider Thermo Fisher offers an extensive range of single-use bioreactor products addressing diverse bioprocessing needs. Backed by strong market presence and R&D investments, the company continues to drive innovation and meet evolving industry demands.

Market Segmentation Insights

By Product:

* Single-use bioreactor systems lead the market due to lower setup costs, reduced operational complexity, and eco-friendly recyclable components.

By Type:

* Stirred-tank bioreactors hold the largest share, valued for their scalability, versatility, and efficient gas/nutrient distribution-ideal for producing vaccines, recombinant proteins, and monoclonal antibodies.

By Molecule Type:

* Monoclonal antibodies (mAbs) dominate, driven by expanding cancer therapies and R&D pipelines.

By Cell Type:

* Mammalian cells remain the most widely used due to their complex metabolic capabilities essential for biologics production.

By Application:

* Bioproduction leads, supported by increasing biopharmaceutical approvals, biosimilar growth, and the expiration of major drug patents.

By End User:

* Pharmaceutical and biotechnology companies represent the largest user segment, attributed to heightened R&D activity and biologics production.

Regional Analysis

* North America: Largest market share, supported by strong biopharma infrastructure and personalized medicine growth.
* Europe: Significant market presence with increasing biologics adoption.
* Asia Pacific: Expected to record the fastest growth, driven by rising biosimilar demand, expanding biomanufacturing capacity, and growth in contract manufacturing.

Key Takeaway

The single-use bioreactors market is witnessing rapid transformation as the biopharmaceutical industry embraces flexibility, scalability, and cost efficiency. With innovation from major players and strong R&D support, SUBs are set to play a pivotal role in the next generation of biologics manufacturing.

Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750&utm_source=abnewswire&utm_medium=referral&utm_campaign=paidpr]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=singleuse-bioreactors-market-to-reach-usd-91-billion-by-2029]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.